BridgeBio Pharma, Inc. (MUN:2CL)
62.18
+7.98 (14.72%)
At close: Dec 1, 2025
BridgeBio Pharma Employees
As of December 31, 2024, BridgeBio Pharma had 730 total employees, including 725 full-time and 5 part-time employees. The number of employees increased by 174 or 31.29% compared to the previous year.
Employees
730
Change (1Y)
174
Growth (1Y)
31.29%
Revenue / Employee
€414,185
Profits / Employee
€933,219
Market Cap
12.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 730 | 174 | 31.29% |
| Dec 31, 2023 | 556 | 160 | 40.40% |
| Dec 31, 2022 | 396 | -182 | -31.49% |
| Dec 31, 2021 | 578 | 182 | 45.96% |
| Dec 31, 2020 | 396 | 148 | 59.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
BridgeBio Pharma News
- 5 days ago - BridgeBio to Participate in the J.P. Morgan Healthcare Conference - GlobeNewsWire
- 8 days ago - BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET - GlobeNewsWire
- 18 days ago - BridgeBio Has More Room To Run - Seeking Alpha
- 19 days ago - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - BridgeBio Pharma (BBIO) Receives Maintained Rating with Raised Price Target | BBIO Stock News - GuruFocus
- 26 days ago - Is the Market Bullish or Bearish on BridgeBio Pharma Inc? - Benzinga
- 4 weeks ago - BridgeBio (BBIO) Unveils Promising Preclinical Data for Cancer Treatment - GuruFocus
- 4 weeks ago - Insider Sell Alert: Maricel Apuli Sells 2,000 Shares of BridgeBio Pharma Inc (BBIO) - GuruFocus